gallic acid has been researched along with Cancer of Cervix in 11 studies
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Several phenolic acids-caffeic and gallic acid derivatives-were synthesized and screened for their potential antiproliferative and cytotoxic properties, in different human cancer cell lines: mammary gland and cervix adenocarcinomas and lymphoblastic leukemia." | 3.72 | Anticancer activity of phenolic acids of natural or synthetic origin: a structure-activity study. ( Andrade, JL; Borges, F; da Cruz, TG; Gomes, CA; Marques, MP; Milhazes, N, 2003) |
| "GA-Fe@EMB can target cervical cancer marker SLC16A1/3 to regulate glycolysis and redox pathways, synergistically with photothermal therapy, which provides a new avenue for the synergistic treatment of malignant cervical cancer." | 1.91 | Construction of SLC16A1/3 Targeted Gallic Acid-Iron-Embelin Nanoparticles for Regulating Glycolysis and Redox Pathways in Cervical Cancer. ( Akram, Z; Li, Y; Li, Z; Sun, S; Xie, Z; You, S; Yu, L; Zhang, J; Zhao, N, 2023) |
| "Ethyl gallate was effective in scavenging 1,1-Diphenyl-2-picrylhydrazyl (DPPH) radicals and the IC₅₀ value was lower than all the positive controls used in this study." | 1.37 | Free radical scavenging, cytotoxic, and hemolytic activities of an active antioxidant compound ethyl gallate from leaves of Acacia nilotica (L.) Wild. Ex. Delile subsp. indica (Benth.) Brenan. ( Kalaivani, T; Mathew, L; Rajasekaran, C, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Gomes, CA | 1 |
| da Cruz, TG | 1 |
| Andrade, JL | 1 |
| Milhazes, N | 1 |
| Borges, F | 1 |
| Marques, MP | 1 |
| Yadav, P | 1 |
| Vats, R | 1 |
| Bano, A | 1 |
| Vashishtha, A | 1 |
| Bhardwaj, R | 1 |
| You, S | 1 |
| Zhang, J | 2 |
| Yu, L | 1 |
| Li, Z | 1 |
| Zhao, N | 1 |
| Xie, Z | 1 |
| Li, Y | 1 |
| Akram, Z | 1 |
| Sun, S | 1 |
| Demir, S | 1 |
| Yaman, SO | 1 |
| Sener, SO | 1 |
| Ayazoglu Demir, E | 1 |
| Aliyazicioglu, R | 1 |
| Ozgen, U | 1 |
| Mentese, A | 1 |
| Deger, O | 1 |
| Aliyazicioglu, Y | 1 |
| Daduang, J | 1 |
| Palasap, A | 1 |
| Daduang, S | 1 |
| Boonsiri, P | 1 |
| Suwannalert, P | 1 |
| Limpaiboon, T | 1 |
| Sanches, PR | 1 |
| Carneiro, BM | 1 |
| Batista, MN | 1 |
| Braga, AC | 1 |
| Lorenzón, EN | 1 |
| Rahal, P | 1 |
| Cilli, EM | 1 |
| Tang, XD | 1 |
| Zhou, X | 1 |
| Zhang, QZ | 1 |
| Le, AD | 1 |
| Zhou, KY | 1 |
| You, BR | 2 |
| Moon, HJ | 1 |
| Han, YH | 1 |
| Park, WH | 2 |
| Kalaivani, T | 1 |
| Rajasekaran, C | 1 |
| Mathew, L | 1 |
| Yi, ZC | 1 |
| Liu, YZ | 1 |
| Li, HX | 1 |
| Yin, Y | 1 |
| Zhuang, FY | 1 |
| Fan, YB | 1 |
| Wang, Z | 1 |
11 other studies available for gallic acid and Cancer of Cervix
| Article | Year |
|---|---|
Anticancer activity of phenolic acids of natural or synthetic origin: a structure-activity study.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Caffeic Acids; Cell Division; Cell Line, Tu | 2003 |
A Phytochemicals Approach Towards the Treatment of Cervical Cancer Using Polyphenols and Flavonoids.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Female; Flavanones; Flavono | 2022 |
Construction of SLC16A1/3 Targeted Gallic Acid-Iron-Embelin Nanoparticles for Regulating Glycolysis and Redox Pathways in Cervical Cancer.
Topics: Female; Gallic Acid; Glycolysis; HeLa Cells; Humans; Iron; Molecular Docking Simulation; Nanoparticl | 2023 |
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; | 2020 |
Gallic acid enhancement of gold nanoparticle anticancer activity in cervical cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chlorocebus aethiop | 2015 |
A conjugate of the lytic peptide Hecate and gallic acid: structure, activity against cervical cancer, and toxicity.
Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Survival; Drug Screening Assays, Antitumor; Erythro | 2015 |
[Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells].
Topics: Catechin; Cell Line, Tumor; Female; Gallic Acid; Human papillomavirus 16; Humans; Hypoxia-Inducible | 2008 |
Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Survival; Drug Screening Assays, Antitumor; E | 2010 |
The effects of mitogen-activated protein kinase inhibitors or small interfering RNAs on gallic acid-induced HeLa cell death in relation to reactive oxygen species and glutathione.
Topics: Cell Death; Female; Gallic Acid; Glutathione; HeLa Cells; Humans; MAP Kinase Signaling System; Mitog | 2011 |
Free radical scavenging, cytotoxic, and hemolytic activities of an active antioxidant compound ethyl gallate from leaves of Acacia nilotica (L.) Wild. Ex. Delile subsp. indica (Benth.) Brenan.
Topics: Acacia; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Cell Proliferation; Chlorocebus ae | 2011 |
Tellimagrandin I enhances gap junctional communication and attenuates the tumor phenotype of human cervical carcinoma HeLa cells in vitro.
Topics: Antineoplastic Agents; Connexin 43; Disease Progression; Dose-Response Relationship, Drug; Drugs, Ch | 2006 |